Nomad Power Solutions (NMAD) Current Assets (2010 - 2026)
Nomad Power Solutions (NMAD) posted Current Assets of $19.3 million for Q2 2026, up 272.68% on a QoQ basis from $5.2 million in Q4 2025, and up 1849.88% year-over-year from $989752.0 in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Current Assets (2010 - 2026) Analysis & Trends
Nomad Power Solutions has reported Current Assets for 17 years, with the latest figure at $19.3 million in Q2 2026.
- On a quarterly basis, Current Assets rose 1849.88% year-over-year to $19.3 million in Q2 2026; TTM through Jun 2026 was $19.3 million, a 1849.88% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, up 352.06% from the prior year.
- Current Assets was $19.3 million for Q2 2026 at Nomad Power Solutions, up from $5.2 million in the prior quarter.
- The five-year high for Current Assets was $19.3 million in Q2 2026, with the low at $989752.0 in Q2 2025.
- Average Current Assets over 5 years is $5.1 million, with a median of $4.3 million recorded in 2023.
- The sharpest annual moves came in 2024 and 2026: Current Assets sank 73.41% in 2024, then jumped 1849.88% in 2026.
- Over 5 years, Current Assets stood at $5.6 million in 2022, then dropped by 22.52% to $4.3 million in 2023, then tumbled by 73.41% to $1.1 million in 2024, then jumped by 352.06% to $5.2 million in 2025, then surged by 272.68% to $19.3 million in 2026.
- The last three Current Assets figures came in at $19.3 million (Q2 2026), $5.2 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - | 19.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.30 Mn |
| Dec 31, 2025 | 5.18 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 989,752.00 |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 3.59 Mn |
| Dec 31, 2023 | 4.31 Mn |
| Sep 30, 2023 | 5.23 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Mar 31, 2023 | 4.33 Mn |
| Dec 31, 2022 | 5.56 Mn |
| Sep 30, 2022 | 6.82 Mn |
| Jun 30, 2022 | 8.02 Mn |
| Mar 31, 2022 | 4.11 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Sep 30, 2021 | 6.31 Mn |
| Jun 30, 2021 | 7.24 Mn |
| Mar 31, 2021 | 7.89 Mn |